Latest filing published 05 Jan 2016 for Alaunos Therapeutics, Inc.. Read the official filing
No signal scores available.
Wyche Fowler appears in our data through filings on Alaunos Therapeutics, Inc. shares, published by SEC (Form 4). We count 3 filings, every one of them for a trade on 31 December 2015.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 5 January 2016, the filings show a share grant in Alaunos Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 5 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations